Trial Profile
Phase I trial of ALD1613 in patients with Congenital Adrenal Hyperplasia
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 13 Nov 2015
Price :
$35
*
At a glance
- Drugs ALD 1613 (Primary)
- Indications Congenital adrenal hyperplasia
- Focus Adverse reactions
- 13 Nov 2015 New trial record